FOXO1 and nasopharyngeal carcinoma: Simultaneously, we found through low-stratified analysis that FOXO1 expression was negatively correlated with NPC survival in clinical stages III–IV but not stages I–II, which hinted that FOXO1 loss promoted the middle and late stages of NPC disease.